Percutaneous treatment of pulmonary embolism during pregnancy

Publication date: Available online 22 January 2020Source: Revista Española de Cardiología (English Edition)Author(s): Ernesto Valero, Jessika González-D’Gregorio, Nieves Carbonell, Mónica García-Simón, José Ferreres, Juan Sanchis
Source: Revista Espanola de Cardiologia - Category: Cardiology Source Type: research

Related Links:

We present a case of a 32-year-old patient who had a pulmonary embolism with shock in the 8th week of pregnancy complicated by atypical hemolytic uremic syndrome.
Source: Journal of Cardiac Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: CASE REPORT Source Type: research
CONCLUSIONS: Even after uncomplicated surgery and postoperative period, NT-proBNP concentrations markedly increase in otherwise healthy adult patients. The aetiology of postoperative NT-proBNP increase is currently unknown and may be multifactorial.PMID:34265286 | DOI:10.1016/j.clinbiochem.2021.07.009
Source: Clinical Biochemistry - Category: Biochemistry Authors: Source Type: research
RARITAN, NJ, June 23, 2021 – The Janssen Pharmaceutical Companies of Johnson &Johnson announced today it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the use of XARELTO® (rivaroxaban) in pediatric patients. The NDA seeks two pediatric indications: treatment of venous thromboembolism (VTE, or blood clots) and reduction in the risk of recurrent VTE in patients aged birth to less than 18 years of age after at least five days of initial parenteral anticoagulant treatment; and thromboprophylaxis (prevention of blood clots) in patients aged 2 years and older with con...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
CONCLUSION: Our results suggest that D-dimer allows to safely rule out VTE in pregnant women with suspected VTE and a disease prevalence consistent with a low/intermediate or unlikely pre-test probability.PMID:34161671 | DOI:10.1111/jth.15432
Source: Thrombosis and Haemostasis - Category: Hematology Authors: Source Type: research
To investigate the trend and outcomes of acute pulmonary embolism (PE) during pregnancy and puerperium using a large national database.
Source: Mayo Clinic Proceedings - Category: Internal Medicine Authors: Tags: Original article Source Type: research
AbstractAntiphospholipid syndrome (APS) is an autoimmune disorder characterized by arterial, venous, and/or small vessel thrombosis, pregnancy morbidity, and persistently elevated levels of antiphospholipid antibodies (aPL). Cardiovascular disease (CVD) in APS can present as heart valvular disease (HVD), macro-micro-coronary artery disease (CAD), myocardial dysfunction, cardiac thrombi, or pulmonary hypertension. Brain disease presents as stroke or transient ischemic attack (TIA) and less frequently as cerebral venous thrombosis, seizures, cognitive dysfunction, multiple sclerosis (MS) −like syndrome, or chorea. Infa...
Source: Clinical Rheumatology - Category: Rheumatology Source Type: research
Pregnancy-associated high-risk pulmonary embolism (PE) is among the most frequent causes of maternal mortality in the Western world, by causing hemodynamic instability and circulatory failure through a large thrombotic pulmonary obstruction. The very challenging management of these dramatic situations comprises the need to quickly select a therapy of pulmonary reperfusion or hemodynamic replacement, while taking into account both maternal and fetal risks. In this review, we discuss the role of risk stratification in pregnancy-associated PE and the available evidence to support the use of thrombolysis, catheter-directed thr...
Source: Thrombosis Research - Category: Hematology Authors: Source Type: research
We describe the management of a case of a primigravida who developed acute PE during induction of labour.
Source: International Journal of Obstetric Anesthesia - Category: Anesthesiology Authors: Source Type: research
Introduction: Pulmonary embolism (PE) remains a leading cause of maternal death in the UK. Pregnancy carries a five to six fold increase in incidence of PE. Caesarean section carries a further 10-20 fold increase in incidence of PE,1 with the peak risk being in the first few days following delivery. PE in the puerperium is fatal in 15%, and of these two-thirds die within 30 min of the embolic event.2 A 2010 audit carried out on our delivery suite found 87 –97% of patients received prophylactic low-molecular weight heparin (LMWH) at the correct dose, time and duration.
Source: International Journal of Obstetric Anesthesia - Category: Anesthesiology Authors: Source Type: research
Rationale: Choriocarcinoma is a highly aggressive tumor. It occurs infrequently during pregnancy. The management of choriocarcinoma during pregnancy poses several challenges. Patient concerns: At 34 weeks of gestation, a 21-year-old primigravida was transferred to the emergency room for cephalgia, reduced fetal movements, and left intra-atrial intracavitary thrombus. Diagnosis: Choriocarcinoma in the third trimester with lung and brain metastases, pulmonary vein thrombosis (PVT), and systemic thrombosis Intervention: An emergency cesarean section was performed. Subsequently, low-molecular-weight ...
Source: Medicine - Category: Internal Medicine Tags: Research Article: Clinical Case Report Source Type: research
More News: Cardiology | Heart | Pregnancy | Pulmonary Thromboembolism